VKTX

Viking Therapeutics Inc

Feb 27 • 04:00PM ET

33.84

+0.87 2.64 %

Healthcare • Biotechnology • USA • NASD

Peers: MDGL AKRO GLMD AKBA ATON ARDX BOLD TVRD EYPT KYNB

| Held by: VTI XBI VB VBK VXF SCHA IWR VHT IWD IWS

Index	-	P/E	-	EPS (ttm)	-3.18	Insider Own	2.96%	Shs Outstand	114.79M	Perf Week	9.06%
Market Cap	3.91B	Forward P/E	-	EPS next Y	-4.57	Insider Trans	-12.22%	Shs Float	112.13M	Perf Month	11.28%
Enterprise Value	3.20B	PEG	-	EPS next Q	-1.00	Inst Own	62.87%	Short Float	23.33%	Perf Quarter	-4.57%
Income	-359.64M	P/S	-	EPS this Y	-32.24%	Inst Trans	-1.26%	Short Ratio	8.72	Perf Half Y	27.12%
Sales	0.00M	P/B	6.08	EPS next Y	-8.41%	ROA	-44.29%	Short Interest	26.16M	Perf YTD	-3.81%
Book/sh	5.57	P/C	5.54	EPS next 5Y	-9.28%	ROE	-47.34%	52W High	43.15 -21.58%	Perf Year	18.03%
Cash/sh	6.11	P/FCF	-	EPS past 3/5Y	-52.71% -42.46%	ROIC	-56.28%	52W Low	18.92 78.86%	Perf 3Y	207.92%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.69% 6.36%	Perf 5Y	402.08%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-215.49%	Oper. Margin	-	ATR (14)	2.02	Perf 10Y	1790.50%
Dividend Ex-Date	-	Quick Ratio	9.33	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	58.31	Recom	1.11
Dividend Gr. 3/5Y	- -	Current Ratio	9.33	EPS Q/Q	-334.74%	SMA20	11.02%	Beta	0.76	Target Price	93.59
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	4.60%	Rel Volume	0.68	Prev Close	32.97
Employees	53	LT Debt/Eq	0.00	Earnings	Feb 11 AMC	SMA200	7.42%	Avg Volume	3.00M	Price	33.84
IPO	Apr 29, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	-55.02% -	Trades		Volume	2,031,467	Change	2.64%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-29-25	Initiated	Canaccord Genuity	Buy	$106
Apr-29-25	Initiated	Cantor Fitzgerald	Overweight	$104
Apr-08-25	Initiated	Goldman	Neutral	$30
Feb-13-25	Initiated	Scotiabank	Sector Outperform	$102
Feb-07-25	Initiated	Citigroup	Neutral	$38
Dec-02-24	Initiated	Piper Sandler	Overweight
Nov-22-24	Initiated	B. Riley Securities	Buy	$109
Nov-04-24	Reiterated	H.C. Wainwright	Buy	$90 → $102
Sep-11-24	Initiated	JP Morgan	Overweight	$80
Jun-27-24	Initiated	Morgan Stanley	Overweight	$105
May-16-24	Upgrade	Raymond James	Outperform → Strong Buy	$115 → $116
Mar-26-24	Reiterated	Oppenheimer	Outperform	$116 → $138
Mar-07-24	Initiated	Jefferies	Buy	$110
Feb-28-24	Reiterated	Oppenheimer	Outperform	$46 → $116
May-31-23	Resumed	ROTH MKM	Buy	$32
Mar-28-23	Reiterated	Maxim Group	Buy	$15 → $25
Mar-17-23	Initiated	Stifel	Buy	$22
Jul-29-21	Resumed	BTIG Research	Buy	$20
May-25-21	Downgrade	Raymond James	Strong Buy → Outperform	$27 → $12
Jun-05-20	Initiated	BMO Capital Markets	Outperform	$14

Show Previous Ratings

Feb-27-26 05:45PM	Why the Market Dipped But Viking Therapeutics, Inc. (VKTX) Gained Today (Zacks)
Feb-25-26 08:40AM	Lilly's GLP-1 Blockbusters Drive 2025 Revenue Surge: What's Ahead? (Zacks)
Feb-24-26 12:00PM	Lilly vs. Novo Nordisk: Obesity Drug Giants' Face-Off in 2026 (Zacks)
10:17AM	Viking Therapeutics, Inc. (VKTX): A Bull Case Theory (Insider Monkey)
Feb-23-26 04:11PM	Novo Nordisk Dives As Next-Gen Obesity Drug Lags Eli Lilly's Kingpin (Investor's Business Daily) +11.05%
02:29PM	Loading…
02:29PM	Viking Therapeutics Stock Gains Amid Obesity Drug Buzz (Benzinga)
01:39PM	Banks, Asset Manager Stocks Plunge On Private Credit Panic: What's Moving Markets Monday? (Benzinga)
Feb-18-26 07:22AM	Can LLY's Next-Gen Obesity Pipeline Sustain Growth Amid Competition? (Zacks)
Feb-17-26 11:04AM	Hims & Hers Faces New Hurdle In Weight-Loss Brawl With Novo Nordisk (Investor's Business Daily) +5.00%
Feb-16-26 10:26AM	NVO Crashes 21% in a Month: Is This an Indication to Sell the Stock? (Zacks)
09:40AM	Wall Street Thinks These 4 Biotech Stocks Will DoubleAt LeastThis Year (24/7 Wall St.)
Feb-13-26 11:26AM	Accessible Health Platforms Gain Scale Across $6T Health and Wellness Market (PR Newswire)
Feb-12-26 11:31AM	Viking Therapeutics Stock Soars: What's Driving The Momentum? (Benzinga) +6.80%
10:07AM	Stocks Mixed on Strength in Chipmakers and Weakness in Cisco Systems (Barchart)
08:42AM	How to Play Eli Lilly Stock Following a Robust Q4 Earnings Report (Zacks)
08:30AM	Loading…
08:30AM	Viking Therapeutics, Inc. Q4 2025 Earnings Call Summary (Moby)
08:03AM	VKTX Posts Wider-Than-Expected Loss in Q4, Stock Up on Pipeline Updates (Zacks)
12:03AM	Viking Therapeutics Inc (VKTX) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Rising ... (GuruFocus.com)
Feb-11-26 06:02PM	Viking Therapeutics Q4 Earnings Call Highlights (MarketBeat)
05:13PM	Cisco Systems, Applovin, Viking: After-Hours Movers (Yahoo Finance Video)
04:33PM	Viking Therapeutics Stock Climbs After Q4 Report: Details (Benzinga)
04:16PM	Viking Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update (PR Newswire)
09:54AM	Is Novo Nordisk's Turnaround Story at Risk After Weak 2026 Outlook? (Zacks)
Feb-10-26 10:49AM	Eli Lilly's 2025 Surge Sets the Stage for Another Big Year in 2026 (Zacks)
Feb-09-26 11:30AM	Robinhood, AppLovin, Rivian and More Stocks With Earnings This Week (Benzinga)
10:12AM	Hims & Hers Halts Knockoff Wegovy Pill After Just Two Days: Here's Why (Investor's Business Daily)
09:55AM	Novo Nordisk Stock Whipsawed by GLP-1 Pill Fears: Relief Ahead? (Zacks)
Feb-07-26 05:22PM	Hims & Hers Health Stops Offering Knockoff Wegovy Pill Amid FDA Crackdown (Investor's Business Daily)
Feb-04-26 04:05PM	Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2025 on February 11, 2026 (PR Newswire) -11.06%
Feb-03-26 07:08PM	The Smartest Growth Stock to Buy With $30 Right Now (Motley Fool)
11:00AM	Loading…
Feb-02-26 11:00AM	AZN Obesity Pipeline to Get a Boost From Deal With China's CSPC (Zacks)
Jan-30-26 05:45PM	Here's Why Viking Therapeutics, Inc. (VKTX) Fell More Than Broader Market (Zacks)
10:06AM	Novo Nordisk Before Q4 Earnings: How Should Investors Play the Stock? (Zacks)
08:47AM	Viking Therapeutics to Report Q4 Earnings: Here's What to Know (Zacks)
Jan-28-26 09:09AM	Roche Reports Upbeat Efficacy Data From Phase II Obesity Study (Zacks)
Jan-27-26 01:35PM	2 Biotech Stocks Set to Rebound in 2026 (Motley Fool)
09:41AM	Novo Nordisk vs. Viking: Which Obesity Drug Stock is the Safer Bet? (Zacks)
Jan-26-26 11:35AM	Eli Lilly or Viking Therapeutics: Which Stock Is More Likely to be a Millionaire-Maker? (Motley Fool)
09:15AM	How Will Ozempic and Wegovy Sales Aid NVO's Upcoming Q4 Results? (Zacks)
03:14AM	Viking Therapeutics, Inc. (VKTX) Advances Obesity Drug Development and Expands Metabolic Disease Pipeline (Insider Monkey)
Jan-24-26 08:35PM	3 Growth Stocks to Invest $1,000 in Right Now (Motley Fool)
01:35PM	The Best Stocks to Invest $40 in to Start the New Year Off Right (Motley Fool)
Jan-23-26 05:45PM	Viking Therapeutics, Inc. (VKTX) Stock Dips While Market Gains: Key Facts (Zacks) -5.49%
05:30AM	Eli Lilly Soared by 39% in 2025, but Here's Another Healthcare Stock to Buy in 2026 (Motley Fool)
Jan-22-26 05:50PM	Viking Therapeutics, Inc. (VKTX) Rises Higher Than Market: Key Facts (Zacks)
Jan-21-26 03:41PM	2 Bargain Stocks You Can Buy for Less Than $100 Right Now (Motley Fool)
10:50AM	1 Stock That Could Soar by 175%, According to Wall Street (Motley Fool)
Jan-20-26 03:25PM	What Happened to Viking Therapeutics in 2025, And Is it a Buy for 2026? (Motley Fool)
08:28AM	3 Biotech Stocks That Look Like "Sure-Fire" Winners in 2026 (MarketBeat)
Jan-19-26 03:23PM	Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All (MarketBeat)
09:59AM	Is Novo Nordisk's Oral Wegovy Driving Strong Early US Demand Already? (Zacks)
Jan-16-26 10:47AM	LLY Stock Falls After FDA Reportedly Delays Obesity Drug Ruling (Zacks) +6.40%
Jan-15-26 05:45PM	Viking Therapeutics, Inc. (VKTX) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks) -7.16%
01:11PM	Wall Street Soars Near Records, AMD And ASML Jump 6%: What's Moving Markets Thursday? (Benzinga)
10:17AM	How Will Mounjaro and Zepbound Sales Aid LLY's Upcoming Q4 Results? (Zacks)
05:10AM	Viking Therapeutics (VKTX) Soars 11.9% on Strong Weight Loss Market Outlook (Insider Monkey)
Jan-14-26 01:25PM	Stocks Drop, Energy Sector Rises As Crude Eyes 6th Day Of Gains: What's Moving Markets Wednesday? (Benzinga) +11.89%
Jan-13-26 09:58AM	Novo Nordisk Soars 19% in a Month: How Should You Play the Stock? (Zacks)
09:06AM	Jim Cramer Says "I'm a Eli Lilly Guy" When Asked About Viking Therapeutics (Insider Monkey)
Jan-12-26 07:00AM	Viking Therapeutics Announces Publication of Results from Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in the Journal Obesity (PR Newswire)
Jan-09-26 05:45PM	Viking Therapeutics, Inc. (VKTX) Outperforms Broader Market: What You Need to Know (Zacks)
09:58AM	VKTX Completes Enrollment in Phase I Maintenance Study of Obesity Drug (Zacks)
07:12AM	Viking Therapeutics completes enrollment in trial of VK2735 (TipRanks)
Jan-08-26 08:38PM	Lightning Round: QXO is a buy, says Jim Cramer (CNBC TV)
09:30AM	Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet (Zacks)
07:00AM	Viking Therapeutics Announces Completion of Enrollment in Maintenance Dosing Clinical Trial of VK2735 in Obesity (PR Newswire)
Jan-07-26 07:00AM	Viking Therapeutics Announces Appointment of Neil Aubuchon as Chief Commercial Officer (PR Newswire)
Jan-06-26 09:41AM	Can the US Launch of NVO's Wegovy Pill Reignite Momentum in 2026? (Zacks)
Jan-05-26 05:50PM	Viking Therapeutics, Inc. (VKTX) Stock Drops Despite Market Gains: Important Facts to Note (Zacks) -9.26%
04:03PM	Viking Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference (PR Newswire)
10:37AM	LLY Up 28% in 3 Months: Is it the Right Time to Invest in the Stock? (Zacks)
08:34AM	Will NVO's Wegovy Pill Approval for Obesity be a Game Changer in 2026? (Zacks)
Jan-02-26 09:01AM	Here's How VKTX's Obesity Drug Is Moving Quickly Through Phase III (Zacks)
Dec-31-25 09:15AM	2 Beaten-Down Stocks That Could Bounce Back in 2026 (Motley Fool)
08:07AM	The End of Shots? 5 Biotech Stocks Rethinking Diabetes (PR Newswire)
Dec-30-25 05:45PM	Viking Therapeutics, Inc. (VKTX) Sees a More Significant Dip Than Broader Market: Some Facts to Know (Zacks)
Dec-29-25 02:34PM	This Small But Mighty Stock Could Surprise Investors in 2026 (Barchart)
Dec-24-25 10:49AM	NVO's First Oral Obesity Pill Approval: What Does it Mean for Lilly? (Zacks)
Dec-23-25 05:45PM	Viking Therapeutics, Inc. (VKTX) Beats Stock Market Upswing: What Investors Need to Know (Zacks)
04:01PM	Novo Nordisk Jumps As FDA OKs Wegovy Pill As First-Ever Oral GLP-1 Weight Loss Drug (Investor's Business Daily)
10:46AM	Novo Nordisk Wins FDA Nod for Oral Wegovy in Obesity, Stock Up (Zacks)
09:30AM	Wall Street Bulls Look Optimistic About Viking Therapeutics (VKTX): Should You Buy? (Zacks)
08:58AM	Premarket Movers: Albemarle Gaining Momentum on Lithium Boom (24/7 Wall St.)
Dec-22-25 06:46PM	Novo Nordisk Jumps As FDA OKs Wegovy Pill As First-Ever Oral GLP-1 Weight Loss Drug (Investor's Business Daily)
06:50AM	Here is Why H.C. Wainwright Sees Immense Upside for Viking Therapeutics (VKTX) (Insider Monkey)
Dec-18-25 01:13PM	Viking Therapeutics, Inc. (VKTX): A Bull Case Theory (Insider Monkey)
12:35PM	2 Growth Stocks to Invest $1,000 in Right Now (Motley Fool)
09:53AM	Can Higher-Dose Wegovy Help Novo Nordisk Regain Obesity Market Share? (Zacks)
Dec-16-25 01:35PM	1 Bold Prediction for Viking Therapeutics in 2026 (Motley Fool)
10:50AM	2 Monster Stocks in the Making to Buy and Hold (Motley Fool)
Dec-15-25 11:11PM	Viking Therapeutics (VKTX) Deemed 'Extremely Attractive' and Undervalued by Canaccord, Cited as Leader in Obesity Clinical Development (Insider Monkey)
05:45PM	Viking Therapeutics, Inc. (VKTX) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks)
10:32AM	CHMP Backs Higher-Dose Wegovy as Novo Nordisk Seeks 2026 EU Approval (Zacks)
Dec-13-25 04:30AM	My Top 10 Stocks to Buy for 2026 (Motley Fool)
Dec-12-25 11:17AM	Eli Lilly's Next-Generation Obesity Drug Secures First Phase III Win (Zacks)
10:37AM	NVO Down 42% Year to Date: Is This an Indication to Sell the Stock? (Zacks)
Dec-11-25 04:28PM	Eli Lilly Puts Obesity Field 'On Notice' With Best-Ever Weight Loss (Investor's Business Daily)
08:10AM	Eli Lilly's Experimental Obesity Drug Cut Weight By 23.7% (Investor's Business Daily)
07:44AM	This is why Viking Therapeutics, Inc. (VKTX) is a Strong Buy on Wall Street (Insider Monkey)
07:35AM	3 Underrated Growth Stocks That Look Like Great Buys Heading Into 2026 (Motley Fool)

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ZANTE GREG	Chief Financial Officer	Jan 05 '26	Sale	32.90	57,661	1,896,969	189,891	Jan 05 08:31 PM
Mancini Marianna	Chief Operating Officer	Jan 05 '26	Sale	32.98	57,661	1,901,405	409,190	Jan 05 08:31 PM
Lian Brian	President & CEO	Jan 05 '26	Sale	32.96	233,409	7,692,121	2,499,291	Jan 05 08:28 PM
FOEHR MATTHEW W	Director	Jan 02 '26	Option Exercise	3.33	16,000	53,280	148,036	Jan 05 08:25 PM
FOEHR MATTHEW W	Director	Jan 02 '26	Sale	35.11	16,000	561,694	132,036	Jan 05 08:25 PM
MARIANNA MANCINI	Officer	Jan 05 '26	Proposed Sale	32.98	57,661	1,901,406		Jan 05 04:32 PM
GREG ZANTE	Officer	Jan 05 '26	Proposed Sale	32.98	57,661	1,901,470		Jan 05 04:30 PM
BRIAN LIAN	Officer	Jan 05 '26	Proposed Sale	32.96	233,409	7,692,134		Jan 05 04:29 PM
MATTHEW W. FOEHR	Director	Jan 02 '26	Proposed Sale	35.11	16,000	561,694		Jan 02 04:46 PM
Mancini Marianna	Chief Operating Officer	Oct 28 '25	Sale	35.00	6,185	216,492	382,467	Oct 28 07:51 PM
Rowland Charles A Jr	Director	Oct 27 '25	Sale	35.57	60,000	2,134,278	30,000	Oct 28 07:49 PM
Lian Brian	President & CEO	Oct 28 '25	Sale	35.01	38,989	1,364,923	2,419,109	Oct 28 07:48 PM
ZANTE GREG	Chief Financial Officer	Oct 28 '25	Sale	35.00	6,185	216,481	173,592	Oct 28 07:47 PM
GREG ZANTE	Officer	Oct 28 '25	Proposed Sale	35.01	6,185	216,531		Oct 28 04:34 PM
MARIANNA MANCINI	Officer	Oct 28 '25	Proposed Sale	35.00	6,185	216,492		Oct 28 04:32 PM
BRIAN LIAN	Officer	Oct 28 '25	Proposed Sale	35.01	38,989	1,364,923		Oct 28 04:27 PM
CHARLES A ROWLAND JR.	Director	Oct 27 '25	Proposed Sale	35.57	60,000	2,134,278		Oct 27 04:25 PM
Lian Brian	President & CEO	Jul 03 '25	Sale	27.80	26,889	747,633	2,388,014	Jul 03 03:31 PM
ZANTE GREG	Chief Financial Officer	Jul 03 '25	Sale	27.76	4,266	118,428	168,660	Jul 03 03:31 PM
Mancini Marianna	Chief Operating Officer	Jul 03 '25	Sale	27.77	4,266	118,473	377,535	Jul 03 03:30 PM
GREG ZANTE	Officer	Jul 03 '25	Proposed Sale	27.76	4,266	118,428		Jul 03 01:07 PM
MARIANNA MANCINI	Officer	Jul 03 '25	Proposed Sale	27.77	4,266	118,473		Jul 03 01:05 PM
BRIAN LIAN	Officer	Jul 03 '25	Proposed Sale	27.80	26,889	747,633		Jul 03 01:01 PM
FOEHR MATTHEW W	Director	Apr 11 '25	Option Exercise	8.00	20,786	166,288	132,036	Apr 14 07:26 PM
Rouan Sarah Kathryn	Director	Mar 31 '25	Buy	24.15	1,240	29,943	1,240	Apr 02 06:29 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

VKTX

Viking Therapeutics Inc

Upgrade your FINVIZ experience